A PHASE 1/2A DOSE ESCALATION STUDY OF AST-OPC1 IN SUBJECTS WITH CERVICAL SENSORIMOTOR COMPLETE SPINAL CORD INJURY
-
- STATUS
- Not Recruiting
Updated on 19 February 2024
Summary
The purpose of this study is to evaluate the safety of 3 sequential escalating doses of AST-OPC1 administered at a single time-point between 14 and 30 days post-injury, inclusive, to subjects with sensorimotor complete cervical spinal cord injuries.
Description
The purpose of this study is to evaluate the safety of 3 sequential escalating doses of AST-OPC1 administered at a single time-point between 14 and 30 days post-injury, inclusive, to subjects with sensorimotor complete cervical spinal cord injuries.
Details
| Condition | spinal cord injury |
|---|---|
| Age | 100years or below |
| Clinical Study Identifier | TX5337 |
| Last Modified on | 19 February 2024 |
How understandable was the trial content above?
Hard to understand
Easy to understand
Similar trials to consider
Loading...
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.